FIZE kUO® is a digital urine output monitoring platform designed for intensive care environment. It continuously measures urine output in real time and sends the data directly to the electronic medical record (EMR). It also provides alerts regarding possible patient conditions. It is typically used by ICU nurses, intensivists, anaesthesiologists, nephrologists, and teams who manage fluid balance and kidney function in critically ill or high-risk patients.
Traditional manual urinometers require intermittent visual assessments, while FIZE kUO® delivers continuous, real-time urine output monitoring. This reduces human error, eliminates delayed charting, reduces nurses’ workload, and allows earlier detection of kidney deterioration and improved assessment of hemodynamic status.
FIZE kUO® platform is comprised of a bedside console unit and a single-use disposable kit that connects to any standard Foley catheter (6-24 Fr). A convenience tray with a pre-connected catheter kit is also available.
The platform is designed to meet hospital IT security standards, including encrypted data transfer, user authentication, and compliance with healthcare privacy regulations such as HIPAA and GDPR when integrated into hospital systems. The system transmits only essential, time-stamped urine output data to the EMR using secure hospital network protocols (HL7 over TCP/IP) and does not receive or store patient externalclinical data. FIZE Medical is certified to ISO 27001 and ISO 27799 information security standards, and the platform has undergone penetration testing to align with healthcare cybersecurity best practices.
Continuous monitoring allows earlier detection of oliguria, catheter obstruction, and acute changes in kidney output. This enables faster recognition of kidney deterioration and changes in systemic perfusion compared with intermittent manual hourly measurements, supporting timelier clinical assessment and intervention.
Major guidelines such as KDIGO recognize urine output as a key diagnostic and staging criterion for acute kidney injury (AKI). Continuous measurement increases the likelihood of early AKI recognition and successful early intervention. In addition, published studies demonstrate that a substantial subset of AKI patients would be identified based on urine output criteria alone and may be missed when relying primarily on serum creatinine.
By continuously tracking urine output over time, the system detects sustained decreases that may indicate declining kidney function, hemodynamic instability, or shock, and presents customizable alerts on the console display.
The platform displays trends, hourly totals, and alerts, helping clinicians quickly assess diuretic response, overall hemodynamic management, and changes in kidney function within minutes.
FIZE kUO® supports HH-AKI eCQM compliance in two complementary ways:
Quality: By providing continuous, accurate, EMR-structured urine output data that fuels the measure’s clinical logic — enabling clinicians to detect and intervene at AKI Stage 1, before patients ever reach the reportable Stage 2 threshold.
Submission: By feeding that data directly into the hospital’s EHR/CEHRT, making it available for automated QRDA Category I file generation and submission to CMS.
FIZE kUO® integrates with major EMR systems, including Epic and Cerner, by transmitting data using HL7. This enables automated, time-stamped urine output documentation directly into the patient record. 7. What clinical evidence supports using real-time urine output data in ICU?Urine output provides a real-time signal of how the kidneys are responding to circulation and hemodynamic support. Changes in urine output often occur early and can indicate evolving renal or hemodynamic stress.
Clinical literature shows that early recognition of reduced urine output is associated with earlier AKI detection, improved hemodynamic management, and better fluid stewardship in ICU patients.
Clinical feedback from users shows 90% satisfaction with ease of setup and workflow integration.
Most ICU teams can become comfortable with the system setup and use after a thorough in-service training session.
FIZE Medical provides on-site training, clinical education, and ongoing 24/7 technical support to the bedside teams
FIZE kUO® is installed at the bedside by hanging the console on the bed rail or mounting it to an IV pole. The system is gravity-agnostic and does not require floor placement. Once connected, it is operational and begins continuous monitoring with no calibration required.
The system generates alerts when urine output falls below predefined thresholds or when flow interruption is detected. Alerts can be configured by the user in accordance with local clinical protocols or patient status.
Yes. Continuous automated measurement eliminates the need for manual hourly urine bag checks and charting.
Yes. The system can continue monitoring during transport and operates for up to four hours on its built-in battery when not connected to external power.
Yes. Hourly totals, cumulative output, and trend graphs are available on the bedside console and EMR.
Yes. The FIZE kUO® disposable kit is sterile and compatible with standard sterile Foley catheters. A convenience tray including a kit pre-connected to a Foley catheter is also available. The bedside console is non-sterile and should be disinfected according to hospital infection control protocols when required.
